Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Hereditary Breast/Ovarian Cancer (brca1, brca2)
Interventions: DRUG: arzoxifene hydrochloride|DRUG: tamoxifen citrate|OTHER: placebo
Sponsor: The Cleveland Clinic
Collaborators: National Cancer Institute (NCI)